Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [399]

Implementing national cancer control plans

Dr Eduardo Cazap and Dr Lisa Stevens

Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )

Comment: Chemotherapy for frail and elderly patients with advanced...

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland...

Prof Bob Li - Memorial Sloan Kettering Cancer Center, New York City, USA

Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers: Results from a phase II basket trial ( Prof Bob Li - Memorial Sloan Kettering Cancer Center, New York City, USA )

Principle and technique for radiofrequency ablation of benign thyroid nodules

Prof Kwang Hwi Lee - Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United...

Principle and technique for radiofrequency ablation of benign thyroid nodules ( Prof Kwang Hwi Lee - Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United Arab Emirates )

Perception of tobacco use in young adults of urban India

Ms Soumita Ghose - Tata Medical Centre, Kolkata, India

Perception of tobacco use in young adults of urban India ( Ms Soumita Ghose - Tata Medical Centre, Kolkata, India )

Updates in head and neck cancers

Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium

Updates in head and neck cancers ( Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium )

First-line pembrolizumab for recurrent/metastatic head and neck squamous cell...

Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer...

First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer Center New Haven, USA )

Cisplatin superior to cetuximab for HPV oropharyngeal cancer

Prof Hisham Mehanna - University of Birmingham , Birmingham, UK

Cisplatin superior to cetuximab for HPV oropharyngeal cancer ( Prof Hisham Mehanna - University of Birmingham , Birmingham, UK )

Cisplatin v cetuximab for HPV associated oropharyngeal cancer

Prof Hisham Mehanna - University of Birmingham , Birmingham, UK

Cisplatin v cetuximab for HPV associated oropharyngeal cancer ( Prof Hisham Mehanna - University of Birmingham , Birmingham, UK )

KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck...

Prof Barbara Burtness - Yale Cancer Center, New Haven, USA

KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale Cancer Center, New Haven, USA )

ESMO 2018: Highlights

Prof Gordon McVie , Will Davies

ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )

The promise of immunotherapy in head and neck, and prostate cancer

Dr Luis Larrea - NISA, Valencia, Spain

The promise of immunotherapy in head and neck, and prostate cancer ( Dr Luis Larrea - NISA, Valencia, Spain )

More from ecancer